16-88653337-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002461.3(MVD):c.1085C>T(p.Pro362Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,600,368 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_002461.3 missense
Scores
Clinical Significance
Conservation
Publications
- porokeratosis 7, multiple typesInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- disseminated superficial actinic porokeratosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MVD | NM_002461.3 | c.1085C>T | p.Pro362Leu | missense_variant | Exon 9 of 10 | ENST00000301012.8 | NP_002452.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MVD | ENST00000301012.8 | c.1085C>T | p.Pro362Leu | missense_variant | Exon 9 of 10 | 1 | NM_002461.3 | ENSP00000301012.3 | ||
MVD | ENST00000565149.5 | n.1644C>T | non_coding_transcript_exon_variant | Exon 5 of 6 | 1 | |||||
MVD | ENST00000561895.1 | n.366C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 | |||||
MVD | ENST00000562981.1 | n.248C>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152192Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.000290 AC: 68AN: 234806 AF XY: 0.000335 show subpopulations
GnomAD4 exome AF: 0.000159 AC: 230AN: 1448176Hom.: 2 Cov.: 32 AF XY: 0.000190 AC XY: 137AN XY: 720748 show subpopulations
GnomAD4 genome AF: 0.000131 AC: 20AN: 152192Hom.: 0 Cov.: 34 AF XY: 0.000148 AC XY: 11AN XY: 74354 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1
The MVD p.Pro362Leu variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs201844867) and in control databases in 71 of 266178 chromosomes at a frequency of 0.0002667 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 57 of 9592 chromosomes (freq: 0.005942), Other in 2 of 6750 chromosomes (freq: 0.000296), European (non-Finnish) in 10 of 123014 chromosomes (freq: 0.000081), East Asian in 1 of 18628 chromosomes (freq: 0.000054) and South Asian in 1 of 28614 chromosomes (freq: 0.000035), but was not observed in the African, Latino, or European (Finnish) populations. The p.Pro362 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at